110 related articles for article (PubMed ID: 11459667)
1. Selectivity enhancement induced by substitution of non-natural analogues of arginine and lysine in arginine-based thrombin inhibitors.
Kokko KP; Arrigoni CE; Dix TA
Bioorg Med Chem Lett; 2001 Jul; 11(14):1947-50. PubMed ID: 11459667
[TBL] [Abstract][Full Text] [Related]
2. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
[TBL] [Abstract][Full Text] [Related]
3. Lactam-conformationally restricted analogs of N alpha-arylsulfonyl arginine amide: design, synthesis and inhibitory activity toward thrombin and related enzymes.
Okayama T; Seki S; Ito H; Takeshima T; Hagiwara M; Morikawa T
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1683-91. PubMed ID: 8536341
[TBL] [Abstract][Full Text] [Related]
4. Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine.
Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Okamoto S; Funahara Y; Hijikata A
J Med Chem; 1980 Aug; 23(8):830-6. PubMed ID: 7401110
[TBL] [Abstract][Full Text] [Related]
5. Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.
Peterlin-Masic L; Mlinsek G; Solmajer T; Trampus-Bakija A; Stegnar M; Kikelj D
Bioorg Med Chem Lett; 2003 Mar; 13(5):789-94. PubMed ID: 12617892
[TBL] [Abstract][Full Text] [Related]
6. Thrombin inhibitors based on ketone derivatives of arginine and lysine.
Jones DM; Atrash B; Ryder H; Teger-Nilsson AC; Gyzander E; Szelke M
J Enzyme Inhib; 1995; 9(1):43-60. PubMed ID: 8568566
[TBL] [Abstract][Full Text] [Related]
7. Thrombin inhibitors. 1. Ester derivatives of N alpha-(arylsulfonyl)-L-arginine.
Okamoto S; Kinjo K; Hijikata A; Kikumoto R; Tamao Y; Ohkubo K; Tonomura S
J Med Chem; 1980 Aug; 23(8):827-30. PubMed ID: 7401109
[TBL] [Abstract][Full Text] [Related]
8. [Antithrombic activity of N(alpha)-lauroyl-L-arginine ethyl ester (LAE) and 9-fluorenylmethoxycarbonyl-L-arginine methyl ester (Fmoc-L-Arg-OMe)].
Poiarkov AA; Poiarkova SA; Kukhar' VP
Ukr Biokhim Zh (1999); 2007; 79(1):124-31. PubMed ID: 18030741
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
[TBL] [Abstract][Full Text] [Related]
10. A predicted tertiary structure of a thrombin inhibitor-trypsin complex explains the mechanisms of the selective inhibition of thrombin, factor Xa, plasmin, and trypsin.
Matsuzaki T; Sasaki C; Umeyama H
J Biochem; 1988 Mar; 103(3):537-43. PubMed ID: 2968979
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine.
Young RJ; Beams RM; Carter K; Clark HA; Coe DM; Chambers CL; Davies PI; Dawson J; Drysdale MJ; Franzman KW; French C; Hodgson ST; Hodson HF; Kleanthous S; Rider P; Sanders D; Sawyer DA; Scott KJ; Shearer BG; Stocker R; Smith S; Tackley MC; Knowles RG
Bioorg Med Chem Lett; 2000 Mar; 10(6):597-600. PubMed ID: 10741561
[TBL] [Abstract][Full Text] [Related]
12. Thrombin inhibitors. 3. Carboxyl-containing amide derivatives of N alpha-substituted L-arginine.
Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Okamoto S; Hijikata A
J Med Chem; 1980 Dec; 23(12):1293-9. PubMed ID: 7452681
[TBL] [Abstract][Full Text] [Related]
13. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of the thrombin selectivity of a ligand that contains the constrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl- piperidin-3-yl)-propanoic acid at P1.
Narasimhan LS; Rubin JR; Holland DR; Plummer JS; Rapundalo ST; Edmunds JE; St-Denis Y; Siddiqui MA; Humblet C
J Med Chem; 2000 Feb; 43(3):361-8. PubMed ID: 10669563
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the relationship between the reactivity of synthetic substrates and thrombin inhibitors and their structure].
Kibirev VK; Gershkovich AA; Serebrianyĭ SB
Ukr Biokhim Zh (1978); 1983; 55(3):271-6. PubMed ID: 6868150
[TBL] [Abstract][Full Text] [Related]
16. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
17. Design rationale, synthesis, and characterization of non-natural analogs of the cationic amino acids arginine and lysine.
Kennedy KJ; Lundquist JT; Simandan TL; Kokko KP; Beeson CC; Dix TA
J Pept Res; 2000 Apr; 55(4):348-58. PubMed ID: 10798380
[TBL] [Abstract][Full Text] [Related]
18. Structural modification of an orally active thrombin inhibitor, LB30057: replacement of the D-pocket-binding naphthyl moiety.
Lee K; Hwang SY; Hong S; Hong CY; Lee CS; Shin Y; Kim S; Yun M; Yoo YJ; Kang M; Oh YS
Bioorg Med Chem; 1998 Jun; 6(6):869-76. PubMed ID: 9681152
[TBL] [Abstract][Full Text] [Related]
19. Enzyme binding selectivity prediction: alpha-thrombin vs trypsin inhibition.
Mlinsek G; Novic M; Kotnik M; Solmajer T
J Chem Inf Comput Sci; 2004; 44(5):1872-82. PubMed ID: 15446847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and inhibiting properties toward trypsin like proteases of N alpha-(N,N-dimethylcarbamoyl)-alpha-azaornitine and alpha-azalysine esters.
Ferraccioli R; Croce PD; Gallina C; Consalvi V; Scandurra R
Farmaco; 1991 Dec; 46(12):1517-31. PubMed ID: 1821631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
